<SEC-DOCUMENT>0001354457-21-001465-index.html : 20211215 <SEC-HEADER>0001354457-21-001465.hdr.sgml : 20211215 <ACCEPTANCE-DATETIME>20211215160945 ACCESSION NUMBER: 0001354457-21-001465 CONFORMED SUBMISSION TYPE: 25-NSE PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20211215 DATE AS OF CHANGE: 20211215 EFFECTIVENESS DATE: 20211215 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 211494321 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Nasdaq Stock Market LLC CENTRAL INDEX KEY: 0001354457 IRS NUMBER: 521165937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE BUSINESS ADDRESS: STREET 1: One Liberty Plaza CITY: New York STATE: NY ZIP: 10006 BUSINESS PHONE: 301-978-4144 MAIL ADDRESS: STREET 1: Office of General Counsel STREET 2: 805 King Farm Blvd. CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: The Nasdaq Stock Market LLC DATE OF NAME CHANGE: 20060224 </SEC-HEADER> <DOCUMENT> <TYPE>25-NSE <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.25 <SEQUENCE>2 <FILENAME>form25.txt <TEXT> Document 2 - file: form25.txt
</DOCUMENT> </SEC-DOCUMENT>